A Founder’s Guide to Product Manufacturing Timelines

A product manufacturing timeline is the complete period from an approved commercial brief to finished goods ready for sale. It includes much more than the production run itself. Development, samples, testing, packaging, artwork, raw-material procurement, scale-up, filling and quality release can each determine the launch date.

Founders often ask how long manufacturing takes when they actually need to know how long the entire product-development pathway will take. A commercial batch may be produced over days, but reaching a production-ready position can take substantially longer. The answer depends on product category, formulation pathway, revisions, testing, components, supplier lead times, approvals and manufacturing capacity.

This guide explains the major stages, which tasks can overlap, what commonly causes delays and how Australian brands can build a realistic launch plan for skincare, cosmetics, haircare, supplements and other formulated products.

There is no universal manufacturing lead time

Two products that appear similar can follow very different timelines. An established private label formula in stock packaging may progress faster than a custom product requiring several sample rounds, specialised ingredients, custom components and extended testing.

Timing is influenced by:

• private label, semi-custom, custom formulation or formula-transfer pathway;
• product format and processing complexity;
• number of products, flavours, fragrances or shades;
• speed and quality of brand approvals;
• raw-material availability and supplier minimums;
• packaging availability, decoration and freight;
• testing program and required time points;
• artwork readiness and label review;
• scale-up requirements and manufacturing capacity;
• filling, assembly and quality-release processes.

For this reason, any date discussed before the brief has been reviewed should be treated as indicative rather than guaranteed.

Stage 1: Commercial scoping

The project begins with the customer, range, priority product, format, claims, price, quantity, packaging, budget, market and launch channel. A complete brief allows the development team to recommend a suitable pathway and identify obvious conflicts.

Scoping slows down when the brand has not agreed internally on the product, cannot identify a budget, or changes its priority during discussions. It moves more efficiently when decision-makers attend the discovery call and required documents are completed promptly.

Founder action

Complete the NDA and project brief, map the full range, rank the products and consolidate questions. Use the private label manufacturing checklist before approaching the manufacturer.

Stage 2: Feasibility and proposal

The manufacturer reviews whether the concept fits its formulation, equipment, batch sizes, filling capability and quality pathway. Ingredient, packaging, testing and commercial assumptions may need further investigation before a proposal can be finalised.

A quotation prepared from a vague brief may require substantial revision later. Providing the target retail price, fill size, first order and annual forecast helps create a more useful commercial assessment.

Stage 3: Formulation and sampling

Development timing varies greatly. An existing private label formula may require selection and brand approval. A semi-custom project may involve agreed modifications. A custom formula requires a technical brief, ingredient work, laboratory samples, structured feedback and approval.

Each sample round involves preparation, assessment and a brand decision. The laboratory cannot progress efficiently while several stakeholders provide conflicting comments or while the brand is still changing the product strategy.

What speeds up sampling?

• a precise sensory and performance brief;
• clear non-negotiables and preferences;
• one consolidated feedback response;
• sample codes and documented approvals;
• specific comments on viscosity, fragrance, colour, flavour or finish;
• quick decisions that remain consistent with the agreed concept.

Read how sampling and formula revisions work for more detail.

Stage 4: Packaging selection and sourcing

Packaging is one of the most common causes of launch delays. Stock components may be available quickly but still require samples, filling review, labels and freight. Custom colours, moulds, decoration or overseas production can introduce much longer lead times and higher minimums.

The packaging schedule should include:

• component search and sample receipt;
• supplier specification review;
• formula and filling assessment;
• compatibility work where relevant;
• quotation and minimum-order confirmation;
• decoration samples or proofs;
• production, freight, customs and delivery;
• inspection and production contingency.

Ordering components before technical review may appear to save time but can create a larger delay if the pack is unsuitable.

Stage 5: Product testing

Testing should be considered during scoping because some protocols operate over defined periods that cannot be compressed simply to meet a launch date. Relevant work may include stability, packaging compatibility, microbiological or preservative efficacy testing, analytical testing and claim substantiation.

The test sample, packaging, conditions, time points, specifications and acceptance criteria need to match the purpose of the work. Changes to the formula or pack can affect whether prior results remain relevant.

Stage 6: Artwork and label approval

Artwork depends on current ingredient information, directions, warnings, fill declaration, claims, business details and component dimensions. A designer cannot complete a correct label using an outdated formula or unconfirmed pack.

Artwork timelines should allow for copy preparation, design, technical review, corrections, printer proofing and final approval. Multiple uncoordinated reviewers create version-control problems. One final, dated and approved file should be identified for production.

Stage 7: Raw-material procurement

Once the production formula and quantity are defined, materials must be available in approved forms and amounts. Supplier lead times, imported ingredients, minimum pack sizes, documentation and substitutions can all affect readiness.

A last-minute substitution is not simply a purchasing decision. It may affect the formula, process, specification, claims or testing and can require technical review.

Stage 8: Scale-up and production preparation

A laboratory formula must be translated into a process suitable for commercial equipment. Mixing, heating, cooling, addition order, shear and hold times behave differently at scale. The manufacturer also needs final specifications, approved components, batch documents and a confirmed production slot.

Scale-up may identify a need for adjustment before routine production. Brands should allow for this possibility rather than treating the first commercial batch as a simple multiplication of the sample.

See what happens during manufacturing scale-up.

Stage 9: Bulk manufacture

The production team weighs and verifies materials, follows the approved manufacturing method, records the batch and performs relevant in-process checks. The time the vessel is occupied depends on the product’s process, including heating, mixing, cooling, maturation or hold requirements.

Production readiness requires every dependency to be available. A confirmed manufacturing slot can still be affected if labels, pumps, a raw material or final approval has not arrived.

Stage 10: Filling, assembly and coding

Bulk product is filled into the approved component, closed, labelled or decorated as agreed, batch coded and assembled into cartons or shipping configuration. Filling speed depends on viscosity, pack type, equipment, unit count and finishing requirements.

Customer-supplied packaging should include an agreed contingency for damage, setup, testing and normal production variance. Supplying exactly the planned number of units can leave the finished quantity short.

Stage 11: Quality review and release

Relevant production and finished-product checks are reviewed against the agreed specification. Documentation is completed and the batch is released under the applicable quality process. The exact release requirements vary by category and project.

Do not schedule customer delivery, a retailer launch or export collection for the moment filling ends. Allow time for quality review, packing, freight booking and normal operational contingency.

Which stages can overlap?

Good project management allows independent tasks to progress in parallel. Packaging research can begin while samples are being assessed. Brand strategy, photography planning and ecommerce structure can progress while technical work continues. Testing and artwork planning may overlap once the required inputs are stable.

However, parallel work should not turn into premature commitment. Bulk packaging should not be ordered before suitability is assessed. Final artwork should not be printed using an unapproved ingredient list. Marketing claims should not be locked before evidence requirements are understood.

Use decision gates rather than one continuous deadline

A useful timeline includes formal decision gates. The project should not move into the next high-cost stage until the required information is approved. Typical gates include commercial brief approval, formula approval, packaging approval, testing-plan confirmation, artwork approval and production readiness.

Decision gates protect both time and budget. They prevent a brand from ordering packaging while the formula is still changing or printing artwork before the claims and ingredient information are settled. Each gate should identify the approver, supporting documents and consequence of later changes.

Separate working time from waiting time

Project schedules should distinguish active technical work from time waiting for founder feedback, supplier delivery, laboratory time points or external approvals. This makes delays easier to diagnose. It also prevents the manufacturer from being held responsible for periods when the project is waiting on a brand decision or third-party component.

What causes the most common delays?

Incomplete briefs

The laboratory or manufacturer repeatedly requests information that should have been defined at the beginning.

Slow or conflicting approvals

Several stakeholders provide different feedback or leave samples and artwork waiting without a decision.

Changing the concept

The customer, format, ingredient strategy, claims, packaging or price position changes during development.

Packaging lead times

Custom components, decoration, freight and supplier minimums take longer than expected or the ordered pack proves unsuitable.

Late testing decisions

The brand discovers close to launch that the formula, packaging or claim requires additional work.

Unrealistic launch commitments

A retailer, event or public announcement fixes a date before the development pathway is confirmed.

The article on common product development mistakes explains how to prevent these problems.

How founders can protect the timeline

1. Map the entire project from brief to quality release.
2. Identify which decisions depend on formula, packaging or test results.
3. Assign one owner and due date to every brand approval.
4. Keep one controlled version of the brief, formula approval and artwork.
5. Order supplier samples early but delay bulk commitments until appropriate.
6. Include testing and external supplier time in the critical path.
7. Plan a realistic contingency rather than using best-case dates.
8. Review progress regularly and escalate missing dependencies promptly.
9. Avoid adding new variants during the final production phase.
10. Set the public launch date only when the major risks are understood.

Building a launch plan backwards

Begin with the desired customer availability date and list every preceding event: freight arrival, warehouse intake, quality release, filling, bulk manufacture, packaging delivery, material delivery, artwork printing, testing decisions, formula approval and development.

Then replace assumptions with supplier or project-specific information. Mark tasks that cannot begin until another task is complete. These dependencies form the critical path. Add contingency where uncertainty is genuine, particularly around development, testing, imported components and first production.

Frequently asked questions

How long does private label manufacturing take?

Timing depends on formula availability, brand approval, packaging, materials, production capacity and quality processes. A project-specific estimate is required.

Is custom formulation always slower?

Custom development generally involves more technical work and approvals than selecting an existing formula, but the total timeline still depends heavily on packaging, testing and brand decisions.

Can packaging and formulation happen together?

Packaging research can begin early, but the final component must be aligned with the formula, filling process and compatibility requirements before bulk commitment.

Can testing be rushed?

Defined test conditions and time points exist for a reason. Discuss the appropriate protocol early rather than relying on a shortened program to rescue an unrealistic date.

When should I announce the launch date?

Wait until the major dependencies, including formulation, testing, packaging and production readiness, have been assessed and the remaining risk is manageable.

What should be ready before production is booked?

The approved formula, specifications, materials, packaging, artwork, testing decisions, quantity, commercial approvals and required documents should align with the manufacturer’s production-readiness process.

Plan manufacturing with Australian Private Label

Australian Private Label supports private label skin care, custom cosmetic formulation, supplement development, product testing and commercial manufacturing.

APL reviews the complete project before confirming timing because the formula, packaging, testing, quantity and supplier dependencies all influence the result.

Important: Any timelines discussed in this article are general planning principles, not a project estimate or guarantee. Development, testing, packaging, manufacturing and release timing must be confirmed for each product.